NASDAQ:ISRG - Intuitive Surgical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $807.39
  • Forecasted Upside: -10.83 %
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
▲ +3.46 (0.38%)

This chart shows the closing price for ISRG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Intuitive Surgical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ISRG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISRG

Analyst Price Target is $807.39
▼ -10.83% Downside Potential
This price target is based on 19 analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $807.39, with a high forecast of $939.00 and a low forecast of $410.00. The average price target represents a -10.83% upside from the last price of $905.42.

This chart shows the closing price for ISRG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 19 polled investment analysts is to buy stock in Intuitive Surgical. This rating has held steady since March 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 6 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 9 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 9 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 8 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/7/2021Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$892.00 ➝ $916.00Low
4/21/2021CitigroupBoost Price Target$862.00 ➝ $939.00High
4/21/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price TargetBuy$862.00 ➝ $939.00High
4/21/2021Morgan StanleyBoost Price TargetEqual Weight$780.00 ➝ $855.00High
4/21/2021SVB LeerinkBoost Price TargetMarket Perform$825.00 ➝ $860.00High
4/21/2021Wells Fargo & CompanyBoost Price TargetOverweight$879.00 ➝ $892.00High
4/21/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$690.00 ➝ $825.00High
4/21/2021JPMorgan Chase & Co.Boost Price TargetOverweight$840.00 ➝ $900.00High
4/21/2021Piper SandlerBoost Price TargetNeutral$735.00 ➝ $840.00High
4/21/2021Robert W. BairdUpgradeNeutral ➝ Outperform$825.00 ➝ $925.00High
4/21/2021OppenheimerUpgradeUnderperform ➝ Market PerformHigh
4/1/2021CitigroupInitiated CoverageBuy$862.00Low
4/1/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$862.00Low
3/31/2021Piper SandlerBoost Price TargetNeutral$730.00 ➝ $735.00High
1/22/2021JPMorgan Chase & Co.Boost Price TargetOverweight$825.00 ➝ $840.00High
1/22/2021Raymond JamesBoost Price TargetOutperform$800.00 ➝ $865.00High
1/22/2021Wells Fargo & CompanyBoost Price TargetOverweight$841.00 ➝ $879.00High
1/22/2021OppenheimerBoost Price TargetUnderperform$365.00 ➝ $410.00High
1/22/2021Piper SandlerBoost Price TargetNeutral$680.00 ➝ $730.00High
12/15/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$780.00Medium
10/16/2020SVB LeerinkBoost Price TargetMarket Perform$690.00 ➝ $725.00High
10/16/2020JPMorgan Chase & Co.Boost Price TargetOverweight$765.00 ➝ $785.00High
10/16/2020Stifel NicolausBoost Price TargetBuy$725.00 ➝ $815.00High
10/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$727.00 ➝ $815.00High
10/16/2020Morgan StanleyBoost Price TargetOverweight$735.00 ➝ $785.00High
10/16/2020Piper SandlerBoost Price TargetNeutral$595.00 ➝ $680.00High
10/15/2020BTIG ResearchReiterated RatingHoldHigh
10/12/2020Raymond JamesBoost Price TargetOutperform$725.00 ➝ $800.00High
9/28/2020ArgusInitiated CoverageBuy$775.00Medium
9/14/2020BTIG ResearchReiterated RatingHoldLow
9/11/2020Wolfe ResearchInitiated CoverageOutperform$789.00Low
9/8/2020Bank of AmericaDowngradeBuy ➝ Neutral$725.00 ➝ $760.00High
9/1/2020Robert W. BairdInitiated CoverageNeutral$700.00High
8/14/2020SVB LeerinkBoost Price TargetMarket Perform$650.00 ➝ $690.00Low
8/3/2020BTIG ResearchReiterated RatingHoldLow
7/22/2020JPMorgan Chase & Co.Boost Price TargetOverweight$600.00 ➝ $700.00High
7/22/2020UBS GroupBoost Price TargetNeutral$565.00 ➝ $670.00Medium
7/22/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$500.00 ➝ $600.00Medium
7/22/2020Morgan StanleyBoost Price TargetOverweight$602.00 ➝ $735.00Medium
7/22/2020Canaccord GenuityBoost Price TargetBuy$562.00 ➝ $725.00Medium
7/22/2020SVB LeerinkBoost Price TargetMarket Perform$590.00 ➝ $650.00Medium
7/22/2020Raymond JamesBoost Price TargetOutperform$600.00 ➝ $725.00Low
7/22/2020Piper SandlerBoost Price TargetNeutral$510.00 ➝ $595.00Medium
7/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$632.00 ➝ $727.00Medium
7/20/2020Sanford C. BernsteinBoost Price TargetOutperform$625.00 ➝ $725.00Medium
7/20/2020Stifel NicolausBoost Price TargetBuy$575.00 ➝ $715.00Medium
7/15/2020SVB LeerinkBoost Price TargetMarket Perform$535.00 ➝ $590.00High
7/13/2020Sanford C. BernsteinReiterated RatingBuy$625.00High
6/18/2020JPMorgan Chase & Co.Boost Price TargetOverweight$565.00 ➝ $600.00Low
6/16/2020OTR GlobalDowngradePositiveLow
6/4/2020Wells Fargo & CompanyBoost Price TargetOverweight$561.00 ➝ $632.00Medium
4/28/2020OppenheimerReiterated RatingSell$365.00High
4/28/2020Piper SandlerDowngradeOverweight ➝ Neutral$570.00 ➝ $510.00Medium
4/19/2020Evercore ISIDowngradeIn-Line ➝ UnderperformLow
4/17/2020UBS GroupLower Price TargetNeutral$620.00 ➝ $565.00Medium
4/17/2020CfraDowngradeHold ➝ SellMedium
4/17/2020Piper SandlerLower Price Target$633.00 ➝ $570.00High
4/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$555.00 ➝ $561.00Medium
4/17/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$595.00 ➝ $500.00Low
4/17/2020Stifel NicolausBoost Price TargetBuy$425.00 ➝ $575.00Low
4/17/2020Canaccord GenuityLower Price TargetAccumulate ➝ Buy$655.00 ➝ $562.00Low
4/17/2020SVB LeerinkDowngradeOutperform ➝ Market Perform$575.00 ➝ $535.00Medium
4/17/2020BTIG ResearchReiterated RatingHoldHigh
4/13/2020Raymond JamesLower Price TargetOutperform$660.00 ➝ $600.00Low
4/9/2020Bank of AmericaReiterated RatingBuy$650.00Low
4/9/2020Evercore ISIDowngradeIn-Line ➝ UnderperformLow
4/8/2020Piper SandlerReiterated RatingBuy$633.00High
4/2/2020Wells Fargo & CompanyLower Price TargetOverweight$655.00 ➝ $545.00Medium
4/1/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMedium
4/1/2020OppenheimerDowngradeMarket Perform ➝ Underperform$365.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$670.00 ➝ $622.00Low
3/24/2020Stifel NicolausLower Price TargetBuy$665.00 ➝ $425.00High
3/17/2020JPMorgan Chase & Co.Lower Price TargetOverweight$665.00 ➝ $575.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$725.00Medium
1/27/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$610.00 ➝ $595.00Low
1/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight$575.00 ➝ $665.00High
1/24/2020Raymond JamesBoost Price TargetOutperform$615.00 ➝ $660.00High
1/24/2020Canaccord GenuityReiterated RatingBuyHigh
1/10/2020Canaccord GenuityReiterated RatingBuy$655.00Low
1/10/2020UBS GroupBoost Price TargetNeutral$590.00 ➝ $620.00Medium
1/10/2020Cantor FitzgeraldReiterated RatingOverweight$620.00 ➝ $690.00Medium
12/17/2019Morgan StanleyBoost Price TargetOverweight$620.00 ➝ $670.00Low
12/9/2019Wells Fargo & CompanyReiterated RatingOverweight$620.00 ➝ $655.00High
11/20/2019OppenheimerInitiated CoverageMarket PerformLow
10/18/2019Piper Jaffray CompaniesSet Price TargetBuy$633.00Low
10/18/2019Royal Bank of CanadaSet Price TargetHold$570.00Low
10/18/2019Morgan StanleySet Price TargetBuy$620.00Low
10/18/2019Wells Fargo & CompanySet Price TargetBuy$620.00Low
10/18/2019Raymond JamesBoost Price TargetBuy$610.00 ➝ $625.00Low
10/18/2019UBS GroupBoost Price TargetNeutral$560.00 ➝ $590.00High
9/13/2019Redburn PartnersInitiated CoverageBuyLow
7/19/2019Northland SecuritiesSet Price TargetSell$375.00Low
7/19/2019Cantor FitzgeraldSet Price TargetBuy$620.00Low
7/19/2019Morgan StanleySet Price TargetBuy$620.00Low
7/19/2019UBS GroupSet Price TargetHold$560.00Low
7/19/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$575.00 ➝ $610.00Medium
7/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$610.00 ➝ $633.00Medium
5/22/2019Piper Jaffray CompaniesUpgradeOverweight$610.00Low
5/14/2019CitigroupLower Price TargetBuy$611.00 ➝ $575.00Low
4/23/2019CitigroupLower Price TargetBuy ➝ Buy$684.00 ➝ $611.00Medium
4/22/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$630.00 ➝ $610.00High
4/22/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$610.00 ➝ $575.00Low
4/21/2019BTIG ResearchReiterated RatingHoldLow
4/18/2019Piper Jaffray CompaniesReiterated RatingOverweight$610.00Low
4/4/2019Cantor FitzgeraldSet Price TargetBuy$620.00Low
4/1/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$630.00 ➝ $630.00Low
4/1/2019Raymond JamesBoost Price TargetOutperform ➝ Outperform$600.00 ➝ $630.00Low
2/28/2019Royal Bank of CanadaSet Price TargetHold$560.00High
1/25/2019Cantor FitzgeraldReiterated RatingBuy$620.00Low
1/25/2019Stifel NicolausLower Price TargetBuy$600.00 ➝ $570.00Low
1/10/2019Northland SecuritiesReiterated RatingSell$375.00Low
1/2/2019CitigroupLower Price TargetBuy ➝ Buy$601.00 ➝ $560.00Low
11/29/2018CitigroupLower Price TargetBuy ➝ Buy$606.00 ➝ $601.00Low
11/27/2018UBS GroupInitiated CoverageNeutral$540.00High
10/31/2018Piper Jaffray CompaniesBoost Price TargetOverweight$613.00 ➝ $625.00Low
10/21/2018BTIG ResearchReiterated RatingHoldMedium
10/19/2018Royal Bank of CanadaReiterated RatingHold$560.00High
10/19/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$620.00 ➝ $630.00High
10/19/2018Piper Jaffray CompaniesBoost Price TargetOverweight$613.00High
10/19/2018Canaccord GenuityUpgradeHold ➝ Buy$550.00 ➝ $610.00High
10/19/2018Cantor FitzgeraldReiterated RatingBuy$620.00High
10/11/2018Morgan StanleyBoost Price TargetOverweight$575.00 ➝ $600.00Low
10/9/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$600.00High
9/12/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$575.00 ➝ $635.00Medium
8/2/2018CitigroupBoost Price TargetBuy ➝ Buy$561.00 ➝ $592.00Low
7/22/2018BTIG ResearchReiterated RatingHoldLow
7/20/2018Northland SecuritiesReiterated RatingSell$300.00Medium
7/20/2018The Goldman Sachs GroupBoost Price TargetBuy$540.00 ➝ $630.00High
7/20/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$515.00 ➝ $600.00High
7/20/2018Morgan StanleyReiterated RatingOverweight ➝ Overweight$535.00 ➝ $575.00High
7/20/2018Royal Bank of CanadaSet Price TargetHold$550.00High
7/20/2018JPMorgan Chase & Co.Reiterated RatingOverweight$575.00High
7/20/2018Cantor FitzgeraldReiterated RatingBuy$510.00 ➝ $620.00High
7/17/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$510.00 ➝ $600.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageOutperform$560.00Medium
6/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$525.00 ➝ $535.00High
4/18/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$465.00 ➝ $510.00Low
4/18/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$410.00 ➝ $430.00High
4/18/2018Royal Bank of CanadaSet Price TargetHold$460.00High
4/18/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$500.00 ➝ $525.00High
4/18/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$480.00 ➝ $515.00High
4/18/2018SVB LeerinkReiterated RatingOutperform$475.00 ➝ $510.00High
4/18/2018Cantor FitzgeraldBoost Price TargetOverweight$510.00High
4/18/2018Piper Jaffray CompaniesBoost Price TargetNeutral$460.00High
2/6/2018CitigroupLower Price TargetBuy ➝ Buy$507.00Medium
1/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$450.00 ➝ $500.00Low
1/26/2018Royal Bank of CanadaBoost Price TargetSector Perform$430.00High
1/26/2018Canaccord GenuityReiterated RatingHold ➝ Hold$380.00 ➝ $410.00High
1/26/2018Cantor FitzgeraldReiterated RatingBuy$490.00High
1/26/2018CitigroupReiterated RatingBuy$531.00High
1/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$475.00High
1/26/2018Piper Jaffray CompaniesReiterated RatingHoldHigh
1/25/2018Stifel NicolausReiterated RatingBuy ➝ Buy$400.00 ➝ $480.00High
1/18/2018SVB LeerinkReiterated RatingOutperform ➝ Outperform$390.00 ➝ $475.00Low
1/11/2018BarclaysReiterated RatingOverweight ➝ Overweight$465.00Medium
1/5/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$410.00Low
1/3/2018Evercore ISIInitiated CoverageIn ➝ In-Line$380.00High
11/18/2017The Goldman Sachs GroupReiterated RatingBuyN/A
10/20/2017BarclaysReiterated RatingOverweightN/A
10/17/2017Canaccord GenuityReiterated RatingHoldN/A
10/16/2017Wells Fargo & CompanyReiterated RatingBuyN/A
10/10/2017WedbushReiterated RatingBuyN/A
9/25/2017WedbushReiterated RatingOutperform$353.33Low
9/5/2017Morgan StanleyReiterated RatingOverweightHigh
9/1/2017Royal Bank of CanadaReiterated RatingHold$333.33N/A
7/26/2017Canaccord GenuityReiterated RatingHold$290.01 ➝ $333.33Low
7/25/2017Morgan StanleyReiterated RatingOverweight$316.68 ➝ $356.67Low
7/24/2017CitigroupReiterated RatingBuy$305.67 ➝ $359.34Low
7/22/2017Stifel NicolausReiterated RatingBuy$283.32 ➝ $366.66Medium
7/21/2017Royal Bank of CanadaReiterated RatingHold$333.33Medium
7/21/2017JPMorgan Chase & Co.Reiterated RatingOverweight$350.01High
7/21/2017BarclaysBoost Price TargetOverweight$290.01 ➝ $333.33High
7/21/2017Cantor FitzgeraldReiterated RatingHold$350.01High
7/18/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$266.67 ➝ $316.68Low
7/12/2017Wells Fargo & CompanyReiterated RatingOutperform$333.33 ➝ $350.01Low
7/11/2017Canaccord GenuityReiterated RatingHold$290.01Low
7/5/2017SVB LeerinkReiterated RatingOutperformMedium
6/29/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$333.33Low
6/15/2017BTIG ResearchReiterated RatingHoldLow
6/1/2017Bank of AmericaReiterated RatingBuy$333.33Low
5/30/2017Canaccord GenuityDowngradeBuy ➝ Hold$290.01Low
5/25/2017Wells Fargo & CompanyReiterated RatingOutperform$333.33Low
5/22/2017Morgan StanleySet Price TargetOverweight$279.99 ➝ $316.68Low
5/16/2017The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$333.33Medium
4/25/2017Jefferies Financial GroupReiterated RatingBuy$225.00Low
4/24/2017WedbushBoost Price TargetOutperform$278.34 ➝ $291.66Low
4/22/2017SVB LeerinkReiterated RatingOutperform$279.99 ➝ $283.32Low
4/22/2017CitigroupReiterated RatingBuy$273.33 ➝ $305.67Low
4/20/2017BTIG ResearchReiterated RatingHoldLow
4/19/2017Stifel NicolausBoost Price TargetBuy$266.67 ➝ $283.32Low
4/19/2017Evercore ISIBoost Price TargetIn-Line$249.99 ➝ $261.66Low
4/19/2017Canaccord GenuityReiterated RatingBuy$266.67 ➝ $290.01Medium
4/19/2017WedbushBoost Price TargetOutperform ➝ Outperform$266.67 ➝ $278.34High
4/19/2017BarclaysReiterated RatingBuy$266.67 ➝ $276.66High
4/17/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$240.00 ➝ $256.68Medium
3/26/2017BarclaysReiterated RatingBuy$266.67Medium
3/24/2017Canaccord GenuityReiterated RatingBuy$266.67Low
2/14/2017Bank of AmericaSet Price TargetBuy$256.68 ➝ $266.67N/A
1/25/2017Canaccord GenuityReiterated RatingBuyN/A
1/14/2017WedbushReiterated RatingOutperform$266.67N/A
1/4/2017Evercore ISIDowngradeBuy ➝ Hold$230.01N/A
10/21/2016BarclaysReiterated RatingOverweight$249.99 ➝ $253.32N/A
10/19/2016Canaccord GenuityBoost Price TargetBuy$249.99 ➝ $266.67N/A
10/19/2016WedbushReiterated RatingOutperform$261.66 ➝ $251.67N/A
10/19/2016Royal Bank of CanadaSet Price TargetHold$249.99 ➝ $253.32N/A
10/19/2016Royal Bank of CanadaBoost Price TargetSector Perform$250.00 ➝ $253.32N/A
10/13/2016Wells Fargo & CompanyInitiated CoverageOutperformN/A
9/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
9/20/2016BTIG ResearchReiterated RatingHoldN/A
9/19/2016SVB LeerinkReiterated RatingOutperform$260.01N/A
8/26/2016Raymond JamesInitiated CoverageOutperformN/A
7/21/2016Northland SecuritiesDowngrade$200.00N/A
7/20/2016Evercore ISIReiterated RatingBuy$250.00 ➝ $258.33N/A
7/20/2016CitigroupBoost Price TargetBuy$241.00 ➝ $259.68N/A
7/20/2016BarclaysBoost Price TargetOverweight$230.00 ➝ $250.00N/A
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$203.34 ➝ $233.34N/A
7/20/2016BTIG ResearchReiterated RatingNeutralN/A
7/20/2016Canaccord GenuityBoost Price TargetBuy$233.34 ➝ $250.00N/A
7/20/2016WedbushBoost Price TargetOutperform$238.32 ➝ $251.67N/A
7/20/2016Stifel NicolausBoost Price TargetBuy$233.34 ➝ $266.67N/A
(Data available from 6/23/2016 forward)
Intuitive Surgical logo
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $905.42
Low: $899.19
High: $911.36

50 Day Range

MA: $844.60
Low: $785.83
High: $901.96

52 Week Range

Now: $905.42
Low: $543.03
High: $911.35


430,186 shs

Average Volume

576,471 shs

Market Capitalization

$107.21 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Intuitive Surgical?

The following Wall Street research analysts have issued research reports on Intuitive Surgical in the last year: Argus, Bank of America Co., BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, SVB Leerink LLC, UBS Group AG, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for ISRG.

What is the current price target for Intuitive Surgical?

18 Wall Street analysts have set twelve-month price targets for Intuitive Surgical in the last year. Their average twelve-month price target is $807.39, suggesting a possible downside of 10.8%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting ISRG will reach $939.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $410.00 for Intuitive Surgical in the next year.
View the latest price targets for ISRG.

What is the current consensus analyst rating for Intuitive Surgical?

Intuitive Surgical currently has 8 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ISRG will outperform the market and that investors should add to their positions of Intuitive Surgical.
View the latest ratings for ISRG.

What other companies compete with Intuitive Surgical?

How do I contact Intuitive Surgical's investor relations team?

Intuitive Surgical's physical mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider's listed phone number is (408) 523-2100 and its investor relations email address is [email protected] The official website for Intuitive Surgical is